Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes. [electronic resource]
Producer: 20150527Description: 469-76 p. digitalISSN:- 1439-3646
- Adamantane -- adverse effects
- Adult
- Asian People
- Blood Glucose
- Body Weight
- China
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptides -- adverse effects
- Drug Therapy, Combination
- Female
- Glucagon-Like Peptide 1 -- adverse effects
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin -- therapeutic use
- Liraglutide
- Male
- Metformin -- therapeutic use
- Middle Aged
- Nitriles -- adverse effects
- Pyrrolidines -- adverse effects
- Treatment Outcome
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.